1.Study on the Association between G-protein ?3 Subunit Gene Polymorphism and the Emotion Trait of Chest Stuffiness and Pains Patients
Chinese Journal of Information on Traditional Chinese Medicine 2006;0(11):-
Objective To explore the relationship between polymorphism of G-protein ?3 subunit (GNB3) gene and the emotion trait of chest stuffiness and pains patient. Methods The GNB3 gene type in 27 patients of depression of chest stuffiness and pains, 40 patients of no depression of chest stuffiness and pains, and 20 patients of healthy subjects (control) was determined by polymerase chain reaction and restriction fragment incision enzyme, and score of depression was evaluated. Result Occurrence of depression in chest stuffiness and pains was significantly higher than that in control (P
2.Application and mechanism of therapeutic principles in Chinese medicine in ventricular reconstruction after myocardial infarction
Yingchun ZHOU ; Yifen WU ; Xuesen ZHANG ; Dan ZHUANG
Chinese Journal of Tissue Engineering Research 2005;9(11):242-243
OBJECTIVE: Ventricular reconstruction after myocardial infarction is one of the important dangerous factors to the remote occurrence of cardiac functional disturbance. Chinese medicine is of unique advantages in the main therapeutic principles and methods for the post-infarct ventricular reconstruction.DATA SOURCES: To search for and proofread the relevant literatures on the researches on post-infarct ventricular reconstruction in Nuclear Journals of Chinese Medicine from January 1987 to December 2003 by www. google. com,Medline. Referring word: ventricular reconstruction,myocardial infarction,removing blood stasis and resolving phlegm,clearing heat and nourishing yin.STUDY SELECTION: Fifty-six papers on post-infarct ventricular reconstruction were selected, excluded the original literatures on non-random researches and included the original literatures on non-blind researches.DATA EXTRACTION: Of 56 papers,14 papers were deleted for they were repeated in the contents in different degrees. The rest 42 papers were classified and 12 papers of which were selected as the references.DATA SYNTHESIS: Myocardial infarction is the syndrome in which the root cause is deficiency and the symptoms are excess. The main therapeutic principles are to benefit qi,eliminate stasis,resolve phlegm,activate blood circulation,regulate qi,strengthen spleen,clear away heat and nourish yin. Of which, benefiting qi is the primary of the treatment for the root cause and nourishing yin is the secondary of the treatment for the root cause. Eliminating stasis and resolving phlegm is the primary of the treatment for symptoms,regulating qi and clearing away heat is the secondary of the treatment for symptoms. To benefit qi and activate blood circulation can improve blood dynamics to probably benefit the protection of ventricular reconstruction by reducing ventricular pressure and vascular resistauce of systematic circulation.CONCLUSION: After myocardial infarction, it happens inadaptable myocardial hypertrophy and external stromal accumulation and fibrosis of cardiac muscles. Long-term application of the principles for eliminating stasis,resolving phlegm,clearing away heat and nourishing yin can resist ventricular reconstruction and improve post-infarct cardiac function.
4.Regulatory Effect of Buyang Hhuanwu Decoction on Rat Myocardial H9C2 Cell Activity Inhibition Induced by Trastuzumab
Yifen WU ; Jun JIA ; Yingchun ZHOU ; Rong LI ; Rongcheng LUO
Journal of Guangzhou University of Traditional Chinese Medicine 2015;(3):475-480
Objective To observe the influence of Buyang Huanwu Decoction ( BYHWD) on the inhibition of rat myocardial H9C2 cell activity and SH2-containing tyrosine phosphatase-1 ( SHP-1) activity induced by trastuzumab, and to explore the possible regulatory mechanism after observing the intervention of BYHWD on rat myocardial H9C2 cell transfected with SHP-1 or SHPC/S-1 gene. Methods The eukaryotic expression vectors pcDNA3.1 (+)- SHP-1 and pcDNA3.1 (+) -SHPC/S–1 were constructed and then were transfected to rat myocardial H9C2 cells using the method of liposome transfection. The cells with positive clones were screened out with G418, and then were cultured with trastuzumab for maintaining growth. Using quantitative RT-PCR, we detected the expression of SHP-1 gene and SHPC/S - 1 gene in rat myocardial H9C2 cells. The phosphatase activity analysis was used for observing the regulatory effect of BYHWD on SHP-1 in myocardial cells. Furthermore, we observed the apoptosis of rat myocardial H9C2 cells by methyl thiazolyl tetrazolium (MTT) assay after treatment with BYHWD. Results Sequencing results indicated the successful construction of eukaryotic expression vectors, which had stable expression in myocardial H9C2 cells even under the intervention of trastuzumab. The results of phosphatase analysis showed that H9C2-SHP-1 had the highest activities of phosphatase, but the activities were decreased after the intervention with BYHWD ( P<0.05) . The results of MTT assay also showed the apoptotic rate of H9C2-SHP-1 cells was decreased after treatment with BYHWD ( P <0.05) . Conclusion BYHWD can promote the proliferation of myocardial H9C2 cells inhibited by trastuzumab, and can regulate the expression of SHP-1 in myocardial cells, which will supply reference to the further study of treatment of trastuzumab-induced cardiac toxicity.
5.Subcutaneous panniculitis-like T-cell lymphoma
Zhiyong HUANG ; Yifen ZHANG ; Jinjun NIE ; Hongyan WU
Chinese Journal of Clinical and Experimental Pathology 2001;(2):110-112
Purpose To inquire into the clinical and pathological features of subcutaneous panniculitis-like T-cell lymphoma. Methods The histopathology and immunophenotypes of subcutaneous panniculitis-like T-cell lymphoma in 8 cases were observed. Results Clinically one or more subcutaneous nodules were first found, then the lesion infiltrated up to the epiderm or down to the fascia. Half of the cases were stable for long time without systematic symptoms. The others got high fever with bone marrow, lymphonode involvement, had tumescent liver, and spleen, and decreasing of the counts of thrombocytes or whole blood cells. A few were accompanied with lethal hematophage syndrome. Some rapidly advanced and died less than 3 years. Pathologically, atypical large, midium-size and small lymphocytes with variable ratio rounded the lipocytes like rosettes and were confluent to small patchs or foci or formed a reticular pattern. There were many karyokineses and karyorrhexis made of distinct karyorrhexis bodies. The histocytes reactively proliferated accompanied with phagoerythrocytic phenomena, and polynuclear giant cells and granulomatoid reaction were found. The tumor cells infiltrated in the lipolubules. They expressed T-cell immunophenotype. Conclusions This tumor is a special type of skin lymphoma involving subcutaneous fat tissue and special clinicophathological features.
6.Expression and its significance of Her-2/neu protein and androgen receptor in human prostate cancer
Yifen ZHANG ; Yongjun JIANG ; Hongyan WU ; Qiang ZHOU ; Yutian DAI ; Zeyu SUN
Chinese Journal of Geriatrics 2011;30(8):671-675
Objective To observe the expression of Her-2/neu protein and androgen receptor (AR) in human prostate cancer and to evaluate their significances in the progression of prostate cancer. Methods The Her-2/neu protein and AR immunohistochemical stain were carried out in human prostate tissue microarray that consisted of prostate cancer (107 cases) and benign prostate tissue (42 cases). The prostate cancer cases were divided into 4 groups: group one (Gleason score 6),group two (Gleasonscore 7), group three (Gleasonscore 8) and group four (Gleasonscore 9) according to the Gleason score. The immunostains immunohistochemical stain were interpreted in two aspects of the staining intensity and the percentage of positive cells. The significance and relationships between the expression of Her-2/neu protein and AR in prostate cancer and benign prostate tissue (BPT) and the grouping of different Gleason scores of prostate cancer were then evaluated. Results The positive expression rate of Her-2/neu protein was significantly higher in prostate cancer tissue than in BPT [43.9%(47/107) vs. 14.3%(6/42), x2=11.562, P=0.009], and the positive expression intensity of Her-2/neu immunoreactivity was also higher (x2= 11.764, P=0.008). There were significant differences in positive expression intensity of Her-2/neu immunoreactivity among the different Gleason scores groups (x2 = 20. 512, P = 0. 015), and the expression intensity was significantly positively correlated with Gleason scores ( r= 0. 269, P = 0. 005). There was significant difference in AR immunoreactivity between in prostate cancer (67 %, 72/107) and in BPT (50 %, 21/42, x2 =3. 843, P=0. 050). Among prostate cancer cases, the positive expression intensity of AR was not significantly different among groups 1 through 4 (x2 = 4. 318, P = 0. 229), and was not significantly correlated with Gleason scores ( r = - 0. 065, P = 0. 505 ). Moreover, the positive expression intensity of Her-2/neu protein was not significantly correlated with that of AR (r = -0. 115, P=0. 237). Conclusions Overexpression of Her-2/neu protein in human prostate cancer tissue suggests that Her-2/neu may have some role in prostate tumorigenesis. Her-2/neu protein expression is positively correlated with Gleason score in prostate cancer, which suggests that Her-2/neu may be a potential prognostic predictor of prostate cancer.
7.Expression of potential molecular markers in prostate cancer: correlation with progression in patients after endocrine therapy
Yangbo GUAN ; Yifen ZHANG ; Hang WEN ; Qiang ZHOU ; Hongyan WU ; Yutian DAI
Chinese Journal of Urology 2009;30(12):848-851
Objective To evaluate the expression of molecular markers in prostate cancer and to clarify the significance of these markers as prognostic indicators for androgen deprivation therapy. Methods A series of 116 prostate cancer patients under androgen deprivation therapy as a single treatment was reviewed. Expression levels of 7 proteins, including androgen receptor(AR),E-cadherin, Chromogranin A(CgA) , Ki-67, Survivin, EZH2 and hepsin, were measured by immunohistochemical staining. Results Of the 7 molecules. Ki67,EZH2 and Survivin expression were significantly associated with several conventional prognostic factors. Univariate analysis identified clinical stage, Glea-son scores,pretreatment serum PSA level, Ki-67 and Survivin expression as significant predictors for prostate-specific antigen (PSA) progression after endocrine therapy. Of these significant factors, Survivin expression, clinical stage and Gleason scores appeared to be independently related to PSA progression after endocrine therapy by multivariate analysis. Furthermore, there were significant differences in PSA progression-free survival according to positive numbers of these three independent risk factors. Conclusion Survivin could be a useful independent prognostic factor in prostate cancer with endocrine therapy, besides clinical stage and Gleason score.
8.Inhibition of Emodin on LPS-induced Nitric Oxide Generation by Suppressing PLC-γ Phosphorylation in Rat Peritoneal Macrophages
Xinyu WANG ; Shouguang CAI ; Yifen WU ; Junying LI ; Wenxiu YANG ; Fen HU
Chinese Herbal Medicines 2010;02(3):189-194
Objective To investigate the inhibitory mechanism of emodin on lipopolysaccharide(LPS)-induced nitric oxide(NO)generation in rat peritoneal macrophages.Methods NO production and iNOS expression were measured through nitrite assay and Western blotting assay,respectively.NF-kB activity and nuclei P65 expression were estimated by dual-luciferase and Western blotting assay,respectively.Intracellular free Ca2+([Ca2+]i)was detected using the ratiometric fluorescent calcium indicator dye,Fura-2,and a microspectrofluorometer.PLC-γphosporylation was analyzed by Western blotting assay.Results First,emodin was found playing active roles in suppressing LPS-induced NF-kB activation in rat peritoneal macrophages.Second,emodin down-regulated transient[Ca2*]i and could increase in NF-kB upstream signal.Finally,emodin suppressed phosphorylation of PLC-γ by LPS stimulation in the upstream of[Ca2+]i.Conclusion Suppression of PLC-γ phosphorylation is involved in emodin inhibiting NO generation by LPS stimulation in rat peritoneal macrophages.
9.Pathogen Distribution and Drug-resistance to Antibacterial Agents Detected in Three Second-class Hospitals in Zhenjiang
Huiping QIAO ; Yajuan SHAO ; Yifen CHEN ; Yulian WU ; Haiqing WANG ; Jianfen JIA
Chinese Journal of Nosocomiology 2006;0(05):-
OBJECTIVE To isolate bacteria from three second-class hospitals in Zhenjiang Jiangsu Provine,to detect their drug(-resistance) to antibacterial(agents) and analyzed the results in order to find out pathogen distribution and drug(-resistance) trend of the common causative organism.METHODS We isolated 1661 strains of bacteria from clinical samples between 2002 and 2004,and analyze their drug-resistance.RESULTS The number of Gram-positive(bacteria) was 634,accounting for 38.2%,from them there were 312 strains of coagulase-negative Staphylococcus epidermidis,and 148(coagulase)-positive S.aureus.Drug-fast of two above staphylococci was similar.The(resistance) rate to penicillin and to oxacillin surpassed 85%,that to erythromycins exceeded 75%,to quinolones and cephalosporins surpassed 30% and 35%,respectively.The resistance rate to(vancomycin) was zero.Gram-(negative) bacteria were 1 027 strains,accounted for 61.8%.(According) to quantity order,the first was Enterobacter(249 strains);then were Klebsiella(226 strains);Escherichia(167 strains);Pseudomonas aeruginosa(136 strains);and Proteus(62 strains).The resistant rate to semisyhthesized penicillins among the first five Gram-(negative) bacteria species,was the most,especially the Proteus.CONCLUSIONS Clinical doctors,the(laboratorians) and detecting infection department in hospital should markedly pay attention to drug-resistant(bacterium) detection,pathogen mutation and drug-resistance trend,in(order) to reasonably use antibacterial(agents).
10.Epidermal growth factor receptor tyrosine kinase inhibitor in treatment of elderly patients with nonsmall-cell lung cancer
Jingying NONG ; Jinghui WANG ; Xinjie YANG ; Yifen SUN ; Xinyong ZHANG ; Yuhua WU ; Xi LI ; Hui ZHANG ; Na QIN ; Quan ZHANG ; Shucai ZHANG
Chinese Journal of General Practitioners 2012;11(3):221-223
Seventy patients with advanced non-small-cell lung cancer (NSCLC) aged 65 or above were treated with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) erlotinib or gefitinib from February 2006 to September 2010. The efficacy and toxicities of treatment were retrospectively analyzed.The overall response rate and disease control rate were 31.4% and 84.3%,respectively. Themedian progression-free survival time and median survival time were 8.0 months and 13.5 months,respectively(P < 0.05 ). One-year survival rate was 54.3%. Response rate ( CR + PR) ( 42.9% ) anddisease control rate (94.3% )in female patients were superior to males (20.0% and 74.3% ) (P < 0.05 ).Non-smoking and PS score < 2 were good predictors for survival.The side effects were generally mild and mainly were skin rash and diarrhea.